

Eli Lilly acquires Curevo, LimmaTech, and Vaccine Co. to expand its infectious disease portfolio and advance long-term disease prevention.
You can purchase shares of Tema Heart & Health ETF (NASDAQ:HRTS) through any online brokerage.
There are no as such competitors for Tema Heart & Health ETF.
There is no analysis for Tema Heart & Health ETF to provide a consensus price target.
The stock price for Tema Heart & Health ETF (NASDAQ: HRTS) is $32.51 last updated April 29, 2026 at 4:04 PM EDT.
There are no upcoming dividends for Tema Heart & Health ETF.
Tema Heart & Health ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Tema Heart & Health ETF.
Under normal circumstances, the Tema Obesity and Cardiometabolic ETF (formerly called Tema Cardiovascular and Metabolic ETF) seeks to achieve its investment objective by investing at least 80 percent of its net assets, which include borrowings for...